Dr Reddy's launched generic Methylprednisolone Sodium Succinate dose in US

Pharma major Dr Reddy's Laboratories Ltd on Tuesday said it has launched its generic Methylprednisolone Sodium Succinate for injection, indicated for various conditions including arthritis, blood disorders and severe allergic reactions..

Pfizer to back startups in India functioning on oncology, digital health

Drug maker Pfizer on Tuesday said it has launched the Pfizer INDovation Program to back healthcare innovation start-ups in India in the areas of oncology and digital health.

Suven Pharma acquires Hyderabad-based formulation manufacturer for Rs 155 crore

Suven Pharmaceuticals on Tuesday said its Board has accepted acquisition of Hyderabad-based formulations manufacturer Casper Pharma Private Limited for Rs 155 crore.

Intas and Axantia signed an agreement to commercialise Ranibizumab in the Middle East

Intas Pharmaceuticals Ltd has signed an exclusive license and supply agreement with Axantia Holding in the Middle East operating through its pharmaceutical subsidiaries.

Mankind Pharma ventures into the Agri-tech industry

Mankind Pharma has announced the launch of Mankind Agritech Pvt Ltd. The firm has entered into the ever-growing Indian agri-Input segment to use technological innovations in the field and bring its expertise to Indian farmlands.

KKR to trade 10% stake in Max Health for Rs 3500 cr over block deals

US private equity company KKR & Co set to raise Rs 3500 crore by selling around 10 percent of its stake in Max Healthcare through multiple block deals on Thursday.

Biological E Ltd to get mRNA technology from WHO to manufacture COVID-19 vaccines

City-based vaccine maker Biological E. Limited on Monday said the firm was selected as a recipient of mRNA technology to develop COVID-19 vaccines from the World Health Organisation.

Govt of Punjab, Roche Pharma India and Niramai Health Analytix joint venture to quicken Breast Cancer management

Department of Health & Family Welfare, Government of Punjab, Roche Pharma India and Niramai Health Analytix has jointly united as part of Punjab Breast Cancer AI-Digital project to accelerate screening and treatment for Breast Cancer

CanSinoBIO's mRNA COVID vaccine candidate has been approved for clinical trials in China

Chinese vaccine developer CanSino Biologics Inc said on Monday its potential COVID-19 vaccine using the messenger RNA technology has been accepted by China's medical products regulator to enter clinical trials.

SII's Covovax for aged 12+ gets panel nod

The Covid-19 working group under the government’s vaccine advisory body has recommended use of the Serum Institute of India’s Covovax

© 2025 India Pharma Outlook. All Rights Reserved.